Select Publications
Journal articles
2018, 'Quantifying the cellular NAD+ metabolome using a tandem liquid chromatography mass spectrometry approach', Metabolomics, 14, http://dx.doi.org/10.1007/s11306-017-1310-z
,2018, 'Quantitation of NAD+: Why do we need to measure it?', BBA - Biochimica et Biophysica Acta, http://dx.doi.org/10.1016/j.bbagen.2018.07.023
,2017, 'Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease', Translational Neurodegeneration, 6, pp. 33, http://dx.doi.org/10.1186/s40035-017-0104-6
,2017, 'Thermo-sensitive TRP channels: Novel targets for treating chemotherapy-induced peripheral pain', Frontiers in Physiology, 8, pp. 1040, http://dx.doi.org/10.3389/fphys.2017.01040
,2017, 'Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes', Scientific Reports, 7, pp. 12685, http://dx.doi.org/10.1038/s41598-017-12858-7
,2017, 'Neuroprotective effects of honokiol: from chemistry to medicine', BioFactors, 43, pp. 760 - 769, http://dx.doi.org/10.1002/biof.1385
,2017, 'Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer’s disease', Current Alzheimer Research, 14, pp. 1000 - 1007, http://dx.doi.org/10.2174/1567205014666170329114445
,2017, 'Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease', Progress in Neurobiology, 155, pp. 76 - 95, http://dx.doi.org/10.1016/j.pneurobio.2015.12.009
,2017, 'Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation', Ageing Research Reviews, 36, pp. 11 - 19, http://dx.doi.org/10.1016/j.arr.2017.02.004
,2017, 'Association of genetic polymorphisms of claudin-1 with small vessel vascular dementia', Clinical and Experimental Pharmacology and Physiology, 44, pp. 623 - 630, http://dx.doi.org/10.1111/1440-1681.12747
,2017, 'Corrigendum: Identification of cerebral metal ion imbalance in the brain of ageing octodon degus [Front. Aging Neurosci., 9, (2017) (66)] DOI: 10.3389/fnagi.2017.00066', Frontiers in Aging Neuroscience, 9, pp. 134, http://dx.doi.org/10.3389/fnagi.2017.00134
,2017, 'Improvement of antioxidant defences and mood status by oral GABA tea administration in a mouse model of post-stroke depression', Nutrients, 9, pp. 446, http://dx.doi.org/10.3390/nu9050446
,2017, 'Neuroprotective effects of citrus fruit-derived flavonoids, nobiletin and tangeretin in Alzheimer’s and Parkinson’s disease', CNS and Neurological Disorders - Drug Targets, 16, pp. 387 - 397, http://dx.doi.org/10.2174/1871527316666170328113309
,2017, 'Resveratrol and Alzheimer’s Disease: Mechanistic Insights', Molecular Neurobiology, 54, pp. 2622 - 2635, http://dx.doi.org/10.1007/s12035-016-9839-9
,2017, 'Identification of cerebral metal ion imbalance in the brain of ageing Octodon degus', Frontiers in Aging Neuroscience, 9, pp. 66 - 66, http://dx.doi.org/10.3389/fnagi.2017.00066
,2017, 'Topoisomerase I inhibition leads to length-dependent gene expression changes in human primary astrocytes', Genomics Data, 11, pp. 113 - 115, http://dx.doi.org/10.1016/j.gdata.2016.12.005
,2017, 'Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers', Alzheimers Dement, 13, pp. 810 - 827, http://dx.doi.org/10.1016/j.jalz.2017.01.008
,2017, 'Molecular targets of Tannic Acid in Alzheimer’s disease', Curr Alzheimer Res, 14, http://dx.doi.org/10.2174/1567205014666170206163158
,2017, 'Cytotoxic Effects of Environmental Toxins on Human Glial Cells', Neurotoxicity Research, 31, pp. 245 - 258, http://dx.doi.org/10.1007/s12640-016-9678-5
,2017, 'Meet our editorial board member', Current Alzheimer Research, 14, pp. 123, http://dx.doi.org/10.2174/156720501402170109162607
,2017, 'Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols', Neuroscience and Biobehavioral Reviews, 73, pp. 39 - 47, http://dx.doi.org/10.1016/j.neubiorev.2016.11.022
,2017, 'Transcriptional response to mitochondrial protease IMMP2L knockdown in human primary astrocytes', Biochemical and Biophysical Research Communications, 482, pp. 1252 - 1258, http://dx.doi.org/10.1016/j.bbrc.2016.12.024
,2017, 'A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin', Current drug targets, 18, pp. 1529 - 1536, http://dx.doi.org/10.2174/1389450117666161227125121
,2017, 'Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis', Neuropharmacology, 112, pp. 346 - 364, http://dx.doi.org/10.1016/j.neuropharm.2016.05.011
,2017, 'Kynurenine pathway metabolism and neuroinflammatory disease', Neural Regeneration Research, 12, pp. 39 - 42, http://dx.doi.org/10.4103/1673-5374.198971
,2017, 'Neuroprotective Effects of Ellagitannins: A Brief Review', Current drug targets, 18, pp. 1518 - 1528, http://dx.doi.org/10.2174/1389450117666161005112002
,2017, 'The application of lipidomics to biomarker research and pathomechanisms in Alzheimer's disease', Current Opinion in Psychiatry, 30, pp. 136 - 144, http://dx.doi.org/10.1097/yco.0000000000000303
,2016, 'Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer's disease', Nutritional Neuroscience, 19, pp. 475 - 483, http://dx.doi.org/10.1179/1476830514Y.0000000131
,2016, 'Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions', Biomedicine and Pharmacotherapy, 84, pp. 892 - 908, http://dx.doi.org/10.1016/j.biopha.2016.10.011
,2016, 'Plant polyphenols as natural drugs for the management of Down syndrome and related disorders', Neuroscience and Biobehavioral Reviews, 71, pp. 865 - 877, http://dx.doi.org/10.1016/j.neubiorev.2016.10.023
,2016, 'Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells', Neurotoxicity Research, 30, pp. 620 - 632, http://dx.doi.org/10.1007/s12640-016-9657-x
,2016, 'Targeting mTOR signaling by polyphenols: A new therapeutic target for ageing', Ageing Research Reviews, 31, pp. 55 - 66, http://dx.doi.org/10.1016/j.arr.2016.07.004
,2016, 'Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system', Scientific Reports, 6, pp. 35391 - 35391, http://dx.doi.org/10.1038/srep35391
,2016, 'Genomic, transcriptomic and proteomic analyses of dehalobacter UNSWDHB in response to chloroform', Environmental Microbiology Reports, 8, pp. 814 - 824, http://dx.doi.org/10.1111/1758-2229.12444
,2016, 'Interference of α-Synuclein Uptake by Monomeric β-Amyloid
2016, 'Quercetin and the mitochondria: A mechanistic view', Biotechnology Advances, 34, pp. 532 - 549, http://dx.doi.org/10.1016/j.biotechadv.2015.12.014
,2016, 'Construction and use of a Cupriavidus necator H16 soluble hydrogenase promoter', PeerJ, 4, pp. e2269 - e2269, http://dx.doi.org/10.7717/peerj.2269
,2016, 'Ginsenoside Rb1 as a neuroprotective agent: A review', Brain Research Bulletin, 125, pp. 30 - 43, http://dx.doi.org/10.1016/j.brainresbull.2016.04.002
,2016, 'Neuroprotective effects of fisetin in alzheimer’s and parkinson’s diseases: From chemistry to medicine', Current Topics in Medicinal Chemistry, 16, pp. 1910 - 1915, http://dx.doi.org/10.2174/1568026616666160204121725
,2016, 'Resveratrol as a potential therapeutic candidate for the treatment and management of alzheimer’s disease', Current Topics in Medicinal Chemistry, 16, pp. 1951 - 1960, http://dx.doi.org/10.2174/1568026616666160204121431
,2016, 'Genetic and environmental factors in vascular dementia: An update of blood brain barrier dysfunction', Clinical and Experimental Pharmacology and Physiology, 43, pp. 515 - 521, http://dx.doi.org/10.1111/1440-1681.12558
,2016, 'Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy', Phytotherapy Research, 30, pp. 532 - 539, http://dx.doi.org/10.1002/ptr.5569
,2016, 'Insights into effects of ellagic acid on the nervous system: A mini review', Current Pharmaceutical Design, 22, pp. 1350 - 1360, http://dx.doi.org/10.2174/1381612822666160125114503
,2016, 'Chlorogenic acid and mental diseases: From chemistry to medicine', Current Neuropharmacology, 14, http://dx.doi.org/10.2174/1570159X14666160325120625
,2016, 'Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease', Oncotarget, 7, pp. 64589 - 64604, http://dx.doi.org/10.18632/oncotarget.10905
,2016, 'Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease (vol 12, pg 298, 2015)', CURRENT ALZHEIMER RESEARCH, 13, pp. 1198 - 1198, http://dx.doi.org/10.2174/156720501310160825221218
,2016, 'Promoting NAD+ metabolism: A new target for treating degenerative disease', Journal of the Australasian College of Nutritional and Environmental Medicine, 35, pp. 3 - 10
,2015, 'Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of Alzheimer's Disease', Brain Pathology, 25, pp. 679 - 691, http://dx.doi.org/10.1111/bpa.12226
,2015, 'Neuroprotective effects of chrysin: From chemistry to medicine', Neurochemistry International, 90, pp. 224 - 231, http://dx.doi.org/10.1016/j.neuint.2015.09.006
,2015, 'Luteolin as an anti-inflammatory and neuroprotective agent: A brief review', Brain Research Bulletin, 119, pp. 1 - 11, http://dx.doi.org/10.1016/j.brainresbull.2015.09.002
,